Nirvamed

NirvaMed is an early-stage medical device company pioneering a novel treatment for ST-Elevation Myocardial Infarction (STEMI) heart attacks designed to substantially reduce heart muscle death and redefine the standard of care

Biotech & Life Sciences

Sector

Seed

Stage

Medical Device Manufacturing

Model

01Company Overview

NirvaMed is an early-stage medical device company pioneering a novel treatment for ST-Elevation Myocardial Infarction (STEMI) heart attacks designed to substantially reduce heart muscle death and redefine the standard of care.

02Backed By1 investor

SVSeaX Ventures→

03Similar Companies